CLINICAL_TRIALS
trial_result
· 2021-07-16
Clinical Trial Update: Topical Aprepitant in Prurigo Patients [Phase 2]
Summary
Phase 2 trial results were posted for a topical formulation of aprepitant in patients with prurigo. The study was sponsored by LEO Pharma and results were poste…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Pruritus | Phase 2 | Status: COMPLETED | Results posted: 2021-07-16